News
The Christie advances openEHR data strategy with Better Meds ePMA contract
Published
10 months agoon
By
News Editor

The Christie NHS Foundation Trust has selected Better Meds for its electronic prescribing and medicines administrations (ePMA) solution.
This follows the successful implementation of Better’s digital health platform and low-code studio at the trust.
The procurement marks the latest advancement of the trust’s bid to move to a new data-centric model with openEHR standards at its core.
The strategy involves modernising systems from a previous siloed-state where data is locked within applications to a data archetype model which facilitates a patient-centric approach.
Alistair Reid-Pearson, Chief Information Officer at The Christie, said:
“Digitally enabling clinical services is the primary mission in our Digital Strategy.
“We needed a module that could level up our core capabilities whilst also plugging into our openEHR data platform.
“The data-centric approach to continuously improve clinical outcomes is pivotal to the strategy.”
The Christie is Europe’s largest single-site cancer centre. It serves a population of over 3.2m people, treats 60,000 patients each year.
It is a research-intensive institution and, as such, the integrity of, and access to, timely data is critical.
This, in combination with the drive for all trusts to implement ePMA meant that adoption of an ePMA solution is a key priority.
The Better Meds solution is built on the Better openEHR platform which underpins the trust’s in-house electronic health record (EHR).
It will facilitate a seamless embedded user interface with clinical staff able to access the medications from within the EHR providing a better user experience and increased efficiency.
The project also plans to integrate the trust’s chemotherapy prescribing system into the Better digital health platform.
iQHealthTech, the supplier of iQemo, have committed to move to openEHR storage standards for key clinical data items.
This will facilitate a single source of truth for allergies, height, weight and prescribing data, which aims to give clinicians a complete patient overview and enable sharing between modules.
Adrian Aggett, Client Director, Better UK & Ireland, said:
“We are delighted to have been chosen by The Christie to provide our award-winning Better Meds ePMA solution.
“Through our ePMA solution, we are committed to supporting The Christie to safely digitise its prescription processes whilst also providing improved access to data via the Better Meds integration with the trust’s in-house EPR and other systems.”
The Christie contract is the latest in a series of contact wins for Better, with Better Meds now live in seven NHS trusts featuring rapid implementations for the Better Team, and their implementation partners.
South Tees, Oxford Health, South London & Maudsley, and North Cumbria have all gone live within the last six-months.
60
SHARES


Microsoft invests £2.5 billion in UK AI


TMS shows promise in tackling depression ‘epidemic’


AI depression app set for NHS clinical trial


UK Biobank releases world’s largest single set of sequencing data


Listen: Longevity, Eastern wisdom and Western science


Fundamental principles of healthcare digital twins


Tackling the diagnostic testing sustainability problem


Gym-going men ‘unaware’ of protein risk to fertility


Anti-choke mug protects Parkinson’s patients


AI model predicts breast cancer risk without racial bias
Sign up for free updates from Health Tech World
Trending stories
- Diagnostics3 weeks ago
3D model will advance understanding of spinal injury pathology
- Opinion6 days ago
Why it’s time to revisit workplace mental health initiatives and make them work for everyone
- AI3 weeks ago
AI can help predict survival outcomes for cancer patients
- Research4 days ago
Tackling the diagnostic testing sustainability problem